Медико-биологический
информационный портал
для специалистов
 
БИОМЕДИЦИНСКИЙ ЖУРНАЛ Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Федеральное государственное бюджетное учреждение науки
"Институт токсикологии Федерального медико-биологического агентства"
(ФГБУН ИТ ФМБА России)

Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 16, Art. 111 (pp. 1282-1301)    |    2015       
»

Modern methods of treatment of intestinal dysbiosis in patients with colon cancer.
A.A. Zakharenko,A.N. Suvorov, I.V. Shlyk, O.A. Ten, A.S. Natkha, A.A. Trushin, M.A. Belyaev, D.O. Akulichev, S.R. Dzhamilov, D.A. Zaycev, V.A. Rybalchenko.

I.P.Pavlov First Saint Petersburg State Medical University



Brief summary

In patients with colorectal cancer in the perioperative period, revealed pronounced changes microbiocenosis of colon, which is characterized by a change in the quantitative and qualitative composition of microflora. It showed a significant inhibition of anaerobic microbial component mainly bifidobacteria and lactobacilli. As a result, saprophytic microbes multiply with highly resistant to drugs, acquire pathogenic properties. The most prominent representative of such microorganisms is a pathogenic strain of Clostridium difficile, often provokes the development of pseudomembranous colitis. Depending on the degree of dysbiosis held various schemes of conservative therapy, and in severe dysbiotic changes, including pronounced diarrhea associated Clostridium dificile - fecal transplantation.


Key words

colorectal cancer, colon dysbiosis, antibiotic-associated diarrhea, fecal transplantation.





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Hanevich M. D. Kolorektalnii rak. Vibor hiryrgicheskogo leche- niya pri tolstokishechnoi neprohodimosti - SPb.: Agraf+, 2008. - 136 s.


2. Gill S.R., Pop M., Deboy R.T. et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.


3. Jykov V.I.,?Perepadya S.V.,?Zaiceva O.V.,?Moiseenko A.S., Gordienko N.A., Bondarenko M.A. Osobennosti mikrobiocenoza kishechnika y bolnih kolorektalnim rakom 2010g.


4. Issledovanie profilya mikrobiocenoza kishechnika y bolnih kolorektalnim rakom. Jykov V.I., Perepadya S.V., Zaiceva O.V., Moiseenko O.V., Perepadya O.V., Gorbach T.V. YDK 616.351-006-089 Harkov. 2010g.


5. Hanevich M.D., Shasholin M.A., Zyazin A.A. Kolorektalnii rak. Podgotovka tolstoi kishki k operacii. Moskva 2003g.


6. Kondakova N.E. Kishechnii disbioz i ego korrekciya y bolnih s hiryrgicheskimi zabolevaniyami tolstoi kishki. Moskva 2004g.


7. Bauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) // Clin. Microbiol. Infect. - 2009; 15: 1067-79.


8. Parfenov A.I., Osipov G.A., Bogomolov P.O. Disbakterioz kishechnika //Konsiliym-Medikym. - 2001. - T.3, N 6.


9. Skvorcov V.V. Disbioz kishechnika i antibiotik-associirovannaya diareya //Lechashii vrach. - Volgograd 2008. -?N?2. - S. 43-47.


10. Bartlett J.C. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease // Ann. Intern. Med. 2006; 145(10): 758- 64.


11. Gilca R, Fortin E, Hubert B et al. Surveillance des diarrhees associees a Clostridium difficile au Quebec - Bilan du 22 aout 2004 au 20 aout 2005. Inst Nat Sante Publ Quebec. 2005. 25


12. McDonald L.C. et al. Recommendation for surveillance of Clostridium difficile-associated disease // Infect. Control. Hosp. Epidemiol. 2007;28(2):140-5.


13. Roberts K. et al. Die Verbreitung von Clostridium difficileSporen durch die Luft // Krh-Hyg. 2008; 30 Heft: 158-162.


14. S. V. Belmer,?A. V. Malkoch,?Kishechnaya mikroflora i znachenie prebiotikov dlya ee fynkcionirovaniya. Moskva 2006g.


15. Barishnikov N.V., Tkachenko E.I., Yspenskii U.P. Cindromi izbitochnogo bakterialnogo rosta (disbioza) v tonkoi kishke i disbioza tolstoi kishki // Vestnik Klyba pankreatologov. Sankt-Peterbyrg ? 2009. ? N 1(2). ? S. 86.-90.


16. Kalinin A.V., Hazanov A.I. Gastroenterologiya i gepatologiya: diagnostika i lechenie: Rykovodstvo dlya vrachei. ? M.: Miklosh, 2007. ? S. 256-268.


17. Baranovskii A.U., Kondrashina E.A.?Disbakterioz i disbioz kishechnika. - SPb.: Piter, 2000. - S. 224.


18. Andersson R.?// Scand. J. Gastroenterol. - 1997. - Vol. 32, N 11. - P.1073-1083.


19. Bengmark S. // Clin. Nutrition. - 1996. - Vol.15. - P.1-10.


20. Korshynov V.M., Smeyanov V.V., Efimov B.A. //?Vesti RAMN.-1996. - N2.- C. 60-65.


21. Fuller R., Gibson G.R. // Scand. J. Gastroenterol. - 1997. - Vol. 32, suppl. 222. - P.18-32.


22. Lobzin U.V., Makarova V.G., Korovyakova E.R.?i dr. // Ros. jyrn. gastroenterol., gepatol., koloproktol. - 1999. - T.8, N3. - S. 64-66.


23. Gravel D, Miller M, Clostridium difficile Surveillance Working Group. Clostridium Difficile Associated Diarrhea in Acute-Care Hospitals Participating in CHISP: November 1, 2004 to April 30, 2005. Montreal PQ: Canadian Nosocomial Infection Surveillance Program (CNISP.PCSIN), 2007.


24. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009; 15: 1554-80.


25. Rasko D. Clostridium difficile healthcare-associated epidemics // Nat. Genet. - 2012; 45 (1): 6-7. doi: 10.1038/ng.2499


26. Zhang F, Luo W, Shi Y, et al. Should we standardize the 1700-yearold fecal microbiota transplantation? Am J Gastroenterol 2012;107: 1755.


27. Eiseman, B., Silen, W., Bascom, G.S. et al.?Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.?Surgery.?1958;?44:?854-859


28. Brandt LJ, Aroniadis OC, Mellow M et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 1079-1087 (2012).


29. Schwan A, Sjolin S, Trottestam U, et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;2:845.


30. Bakken J.S., Borody T., Brandt L.J., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011;9:1044-9.


31. Aas J., Gessert C.E., Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003;36:580-5.


32. Lund-Tonnesen S., Berstad A., Schreiner A., et al. Clostridium difficile associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen 1998;118:1027-30.


33. Persky S., Brandt L.J. Treatment of recurrent Clostridium difficileassociated diarrhea by administration of donated stool directly though a colonoscope. Am J Gastroenterol 2000;95:3283-5.


34. Maria M Oliva-Hemker. Fecal matters: treating infection with stool transplants 2015


35. Bakken J.S. Fecal bacteriotherapy for recurrent Clostridium diffi cileinfection . Anaerobe 2009 ; 15 : 285 - 9.


36. Gough E , Shaikh H , Manges AR . Systematic review of intestinal microbiota transplantation for recurrent Clostridium difficile infection . Clin Infect Dis 2011 ; 53 : 994 - 1002.


37. Guo B , Harstall C , Louie T et al. Systematic review: faecal transplantation for the treatment of Clostridium difficile associated disease . Aliment Pharmacol Th er 2012 ; 35 : 865 - 75 .


38. Borody TJ , Khoruts A . Fecal microbiota transplantation and emerging applications . Nat Rev Gastroenterol Hepatol 2011 ; 9 : 88 - 96 .


39. Li Wen, Ruth E., Pavel V. Volchkov, Peter B. Stranges, Lia Avanesyan, Austin C. Stonebraker, Changyun Hu, F. Susan Wong, Gregory L. Szot, Jeffrey A. Bluestone, Jeffrey I. Gordon, and Alexander V. Chervonsky Innate immunity and intestinal microbiota in the development of Type 1 diabetes NIH Public Access Author Manuscript. Nature. 2008; 455(7216): 1109-1113.


40. Caricilli A.M.,?Picardi P.K.,?de Abreu L.L.,?Ueno M.,?Prada P.O.,?Ropelle E.R.,?Hirabara S.M.,?Castoldi Â.,?Vieira P.,?Camara N.O.,?Curi R.,?Carvalheira J.B.,?Saad M.J. Gut?microbiota?is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol. 2011 e1001212.


41. Borody T., Warren E., Leis S., Surace R., Ashman O. and Siarakas S. (2004) Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 38: 475-483.


42. Gough E., Shaikh H. and Manges A. (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53: 994-1002.


43. Rohlke F., Surawicz C. and Stollman N. (2010) Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 44: 567-570.


44. Aas J., Gessert C. and Bakken. J. (2003) Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36: 580-585.


45. Bowden T., Jr, Mansberger A., Jr, and Lykins L. (1981) Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 47: 178-183.


46. Garborg K., Waagsbo B., Stallemo A., Matre J. an Sundoy A. (2010) Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 42: 857-861.


47. Hamilton M., Weingarden A., Sadowsky M. and Khoruts A. (2012) Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107(5): 761-767.


48. Kassam Z., Hundal R., Marshall J. and Lee C (2012) Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 172: 191-193.


49. Lund-Tonnesen S., Berstad A., Schreiner A. and Midtvedt T. (1998) Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen 118: 1027-1030.


50. Landy J., Al-Hassi H., McLaughlin S., Walker A., Ciclitira P., Nicholls R. et al., (2011) Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Thera 34: 409-415.


51. Kelly C., De Leon L. and Jasutkar N. (2012) Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 46: 145-149.


52. Mattila E., Uusitalo-Seppala R., Wuorela M., Lehtola L., Nurmi H., Ristikankare M. et al., (2012) Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection Gastroenterology 142(3): 490-6.


53. Mellow M. and Kanatzar A. (2011) Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection - results and follow-up. J Okla State Med Assoc 104(3): 89-91.


54. Russell G., Kaplan J., Ferraro M. and Michelow I. (2010) Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 126: e239-e242.


55. Persky S.E., Brandt L.J. Treatment of recurrent Clostridium difficile-associated diarrhoea by administration of donated stool directly through a colonoscope. Am J Gastroenterology 2000; 95: 3283-5.


56. Borody T.J., Warren E.F., Leis S., et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 42-7.


57. Yoon S.S., Brandt L.J. Treatment of refractory recurrent C. difficile-associated disease by donated stool transplant via colonoscopy. A case series of 12 patients. J Clin Gastroenterol 2010; 44: 562-6.


58. Garborg K., Waagsbo B., Stalleman A., et al. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 2010; 42: 857-61.


59. MacConnachie A.A., Fox R., Kennedy D.R., Seaton R.A. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. Q J Med 2009; 102: 781-4.


60. Rubin T.A., Fessert C.E., Aas J. Stool transplantation for older patients with Clostridium difficile infection. JAGS 2009; 57: 2386-7.


61. Van Nood E.,?Speelman P.,?Kuijper E.J.,?Keller J.J. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill.?2009?Aug 27;14(34). pii: 19316.


62. Drekonja?D.,?Reich J.,?Gezahegn S.,?Greer N.,?Shaukat A.,?MacDonald R.,?Rutks I.,?Wilt T. Fecal Microbiota Transplantation for?Clostridium Difficile?Infection: A Systematic Review of the Evidence Washington (DC):?Department of Veterans Affairs (US); 2014


63. Sposob polycheniya aytoprobiotika na osnove Enterococcus faecium, predstavitelya indigennoi mikroflori kishechnika hozyaina. Syvorov A.N., Simanenkov V.I., Syndykova Z.R., Ermolenko E.I., Capieva A.N., Donec V.N., Soloveva O.I.. Pat.2460778 Sankt-Peterbyrg 2012g.



Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100